Lung cancer is the leading cause of cancer deaths, and lung cancer screening through low-dose CT scans could save more lives than breast cancer screening. However, less than 10% of eligible Americans are screened each year. An important reason for this lack of appropriate screening is that lung cancer screening requires the review of patient-specific benefit and risk information using a decision aid, but such shared decision making is cumbersome without effective decision support tools integrated with the EHR.
Decision Precision+ is an EHR-integrated decision aid that provides individualized benefit and risk information using state-of-the art risk models from the National Cancer Institute. It is seamlessly integrated with the EHR and enables high-quality shared decision making in busy clinical settings. After deployment at University of Utah Health, the rate of lung cancer screening increased over 3-fold in primary care (JAMA Open 2024, CHEST 2023).
Summary
Decision Precision+ is a SMART on FHIR application that pulls in a wide range of relevant data from the EHR and provides patient-specific guidance on benefits and risks. The tool uses the U.S. Preventive Services Task Force guidelines to determine which patients should be considered for lung cancer screening, then uses lung cancer risk and life expectancy models from the National Cancer Institute (https://dceg.cancer.gov/tools/risk-assessment/lcrisks) to provide patient-specific benefit and risk information.
A stand-alone version of the tool, known as Decision Precision, is available to all at https://screenlc.com/. The EHR-integrated version of the tool is also available for free.
The initial development of the standalone Decision Precision tool was funded by the Veterans Administration, with the work led by Dr. Tanner Caverly and Dr. Angie Fagerlin. The subsequent conversion of the tool into the EHR-integrated Decision Precision+ tool was funded by the Agency for Healthcare Research and Quality (AHRQ) (R18 HS026198), with the work led by Dr. Kensaku Kawamoto. A subsequent AHRQ grant is supporting the development of a complementary patient engagement tool known as MyLungHealth, as well as the provision of free dissemination and implementation support to any health systems interested in incorporating Decision Precision+ into their lung cancer screening programs (R18 HS028791).
Technical Details
Screenshot
A screenshot of Decision Precision+ is provided below: